DRHP Filed — Dates AwaitedMAINBOARDOfficial SEBI Filing

Ujin Pharma Ltd.

Price Band

—

Total Issue Size

—

Bidding Window

—

Market Lot

—

Subscription

—

Issue Timeline & Lifecycle

DRHP Filed

26 Jun 2026

Issue Opens

Not announced

Issue Closes

Not announced

Allotment

Not announced

Exchange Debut

Not announced

DRHP Filed

26 Jun 2026

Issue Opens

Not announced

Issue Closes

Not announced

Allotment

Not announced

Exchange Debut

Not announced

AI Company Profile

AI Snapshot

Ujin Pharma Ltd. IPO

HQ:610/6th, floor Neelkanth Corporate Park, Kirol Road, Vidyavihar West, Mumbai – 400 086, Maharashtra, India

What Looks Strong

The offer document states no strength that could be verified.

What to Watch

The offer document states no risk factor that could be verified.

Fundamentals & Key Metrics

Period:ASOF20251231· Multiples Annualised

Profitability & Returns

2 items

RoNWℹ

10.15%

Book Valueℹ

₹4.91

Financial Health & Solvency

1 item

Net Worthℹ

₹27 Cr

Financials at a glance

Restated Consolidated

Statement: Income StatementPeriod: Restated Multi-Year (FY)

Shareholding, Ownership & Dilution

3 disclosed holders

Pre-Offer Shareholding Distribution

Breakdown of major disclosed shareholders prior to the issue

100.00% Pre-Issue

100%Pre-Offer

Umang Ketan Mehta

49.24%

Jinesh Rasiklal Sheth

49.24%

Ami Rupesh Doshi

1.50%

Ownership Impact of the IPO

What is newly issued, what changes hands, and what stays put

100.00% Post-Issue

100%POST-OFFER

Pre-IPO Retained

71.36%

Fresh-Issue Dilution

17.75%

OFS Changes Hands

10.89%

Total Company Offered in IPO28.64%

Calculated from share counts disclosed in the offer filing.

Disclosed Pre-Offer Shareholders Table

AI Summary

Filing-backed

Prospectus Research

Analyze business model, competitive strengths, use of issue proceeds, and disclosed risk factors with official page citations.

Issue intermediaries

Lead book managers

SMC Capitals Limited, Marwadi Chandarana Intermediaries Brokers Private Limited

Registrar to the issue

KFin Technologies Limited

Listing venues

NSE,BSE

Listed Peer Valuation & Returns

Swipe left / right to view all valuation metrics→

Company
Alkyl Amines Chemical Limited	₹0.20 Cr	273.96%

Official Prospectus Filings

Ujin Pharma Ltd. - DRHP Ujin Pharma Ltd- Draft Abridged Prospectus

Type: DRHP · Published: 2026-06-26

Ujin Pharma Ltd. IPO — Dates, Price Band, Lot Size, Financials & Prospectus Analysis | Anvest

Ujin Pharma Ltd.

Issue Timeline & Lifecycle

What Looks Strong

What to Watch

Profitability & Returns

Financial Health & Solvency

Disclosed Pre-Offer Shareholders Table

AI Summary

Prospectus Research

Issue intermediaries

Listed Peer Valuation & Returns

Official Prospectus Filings

Frequently Asked Questions